Trial Profile
A Phase II Study of Multiple Doses of Intravenous Puricase in Subjects With Hyperuricemia and Refractory Gout
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pegloticase (Primary)
- Indications Gout; Hyperuricaemia
- Focus Therapeutic Use
- 23 Aug 2006 Status change
- 26 Oct 2005 New trial record.